枣仁安神胶囊联合劳拉西泮对失眠症患者入睡潜伏期及神经递质水平的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R256.23

基金项目:

浙江省基础公益研究计划项目(LGF21H090002)


Effect of Zaoren Anshen Capsules Combined with Lorazepam on Sleep Latency and Levels of Neurotransmitters of Patients with Insomnia
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察枣仁安神胶囊联合劳拉西泮对失眠症患者入睡潜伏期及血清5-羟色胺(5-HT)、神经 肽Y(NPY) 水平的影响。方法:将温州市第七人民医院于2021年6月—2023年1月收治的116例失眠症患者 按随机数字表法分为西药组、中西药联用组各58例。西药组采用劳拉西泮治疗,中西药联用组采用枣仁安神 胶囊联合劳拉西泮治疗。2组均治疗4周。比较2组睡眠相关指标、神经递质指标(5-HT、NPY) 水平、临床 疗效和不良反应发生率。结果:中西药联用组总有效率为96.55%(56/58),西药组为82.76%(48/58),组间比 较,差异有统计学意义(P<0.05)。治疗后,2组入睡潜伏期、觉醒次数均较治疗前减少(P<0.05),总睡眠 时间均较治疗前延长(P<0.05);且中西药联用组入睡潜伏期、觉醒次数少于西药组(P<0.05),总睡眠时间 长于西药组(P<0.05)。治疗后,2组血清5-HT、NPY水平均较治疗前升高(P<0.05),且中西药联用组2项 指标水平均高于西药组(P<0.05)。中西药联用组不良反应发生率为6.90%(4/58),西药组为12.07%(7/58), 组间比较,差异无统计学意义(P>0.05)。结论:枣仁安神胶囊联合劳拉西泮能够有效缩短失眠症患者的入睡 潜伏期,改善睡眠质量及相关神经递质水平。

    Abstract:

    Abstract: Objective: To observe the effect of Zaoren Anshen Capsules combined with Lorazepam on sleep latency and levels of serum 5-hydroxytryptamine (5-HT) and neuropeptide Y (NPY) in patients with insomnia. Methods:A total of 116 patients with insomnia admitted to the Wenzhou Seventh People's Hospital from June 2021 to January 2023 were divided into the western medicine group and the integrated Chinese and western medicine combination group according to the random number table method,with 58 cases in each group. The western medicine group was treated with Lorazepam,and the integrated Chinese and western medicine combination group was treated with Zaoren Anshen Capsules combined with Lorazepam. Both groups were treated for four weeks. The sleep-related indicators, levels of neurotransmitters (5-HT and NPY), clinical effects and incidence of adverse reactions were compared between the two groups. Results:The total effective rate was 96.55% (56/58) in the integrated Chinese and western medicine combination group, and 82.76% (48/58) in the western medicine group, the difference being significant (P<0.05). After treatment, the sleep latency and number of awakenings in the two groups were reduced when compared with those before treatment (P<0.05),and the total sleep time was prolonged when compared with that before treatment (P<0.05); the latency to fall asleep and the number of awakenings in the integrated Chinese and western medicine combination group were lower than those in the western medicine group (P<0.05), and the total sleep time was longer than that in the western medicine group (P<0.05). After treatment,the levels of serum 5-HT and NPY in the two groups were elevated when compared with those before treatment (P<0.05), and the above two levels in the integrated Chinese and western medicine combination group were higher than those in the western medicine group (P<0.05). The incidence of adverse reactions was 6.90% (4/58) in the integrated Chinese and western medicine combination group, and 12.07%(7/58) in the western medicine group, there being no significance in the difference (P>0.05). Conclusion:The therapy of Zaoren Anshen Capsules combined with Lorazepam can effectively shorten the sleep latency of insomnia patients,and improve the sleep quality and levels of related neurotransmitter.

    参考文献
    相似文献
    引证文献
引用本文

单建敏,徐道祥.枣仁安神胶囊联合劳拉西泮对失眠症患者入睡潜伏期及神经递质水平的影响[J].新中医,2025,57(4):27-30

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-03-03
  • 出版日期:
文章二维码